Follow
Andrew Mooney
Andrew Mooney
Unknown affiliation
Verified email at nhs.net
Title
Cited by
Cited by
Year
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.
AJ Baker, A Mooney, J Hughes, D Lombardi, RJ Johnson, J Savill
The Journal of clinical investigation 94 (5), 2105-2116, 1994
5151994
Does narrative information bias individual's decision making? A systematic review
A Winterbottom, HL Bekker, M Conner, A Mooney
Social science & medicine 67 (12), 2079-2088, 2008
4642008
p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis
A Schürmann, AF Mooney, LC Sanders, MA Sells, HG Wang, JC Reed, ...
Molecular and cellular biology 20 (2), 453-461, 2000
4582000
Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic …
JA Hussain, A Mooney, L Russon
Palliative medicine 27 (9), 829-839, 2013
2362013
Renal association clinical practice guideline on haemodialysis
D Ashby, N Borman, J Burton, R Corbett, A Davenport, K Farrington, ...
BMC nephrology 20, 1-36, 2019
2072019
Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
J Floege, W Kriz, M Schulze, M Susani, D Kerjaschki, A Mooney, ...
The Journal of clinical investigation 96 (6), 2809-2819, 1995
1781995
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document …
K Farrington, A Covic, I Nistor, F Aucella, N Clyne, L De Vos, A Findlay, ...
Nephrology Dialysis Transplantation 32 (1), 9-16, 2017
1502017
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2)
K Farrington, A Covic, F Aucella, N Clyne, L De Vos, A Findlay, D Fouque, ...
Nephrology Dialysis Transplantation 31 (suppl_2), ii1-ii66, 2016
1352016
Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via β1 integrin-mediated survival signals
A Mooney, K Jackson, R Bacon, C Streuli, G Edwards, J Bassuk, J Savill
The American journal of pathology 155 (2), 599-606, 1999
1171999
Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis.
J Hughes, RJ Johnson, A Mooney, C Hugo, K Gordon, J Savill
The American journal of pathology 150 (1), 223, 1997
1151997
Choosing dialysis modality: decision making in a chronic illness context
A Winterbottom, HL Bekker, M Conner, A Mooney
Health Expectations 17 (5), 710-723, 2014
1002014
Patient acceptability of the Yorkshire Dialysis Decision Aid (YoDDA) booklet: a prospective non-randomized comparison study across 6 predialysis services
AE Winterbottom, T Gavaruzzi, A Mooney, M Wilkie, SJ Davies, D Crane, ...
Peritoneal Dialysis International 36 (4), 374-381, 2016
972016
Patient stories about their dialysis experience biases others’ choices regardless of doctor’s advice: an experimental study
AE Winterbottom, HL Bekker, M Conner, AF Mooney
Nephrology Dialysis Transplantation 27 (1), 325-331, 2012
912012
Apoptosis and renal scarring.
J Savill, A Mooney, J Hughes
Kidney international. Supplement 54, S14-7, 1996
751996
The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis
T Sato, MGA Van Dixhoorn, FA Prins, A Mooney, N Verhagen, Y Muizert, ...
Journal of the American Society of Nephrology 10 (6), 1242-1252, 1999
741999
Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis.
A Mooney, T Jobson, R Bacon, M Kitamura, J Savill
Journal of immunology (Baltimore, Md.: 1950) 159 (8), 3949-3960, 1997
711997
Evaluating the quality of patient leaflets about renal replacement therapy across UK renal units
A Winterbottom, M Conner, A Mooney, HL Bekker
Nephrology Dialysis Transplantation 22 (8), 2291-2296, 2007
602007
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation
MPW Smith, A Zougman, DA Cairns, M Wilson, T Wind, SL Wood, ...
Kidney international 84 (6), 1214-1225, 2013
572013
Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
M Burg, T Ostendorf, A Mooney, KM Koch, J Floege
Laboratory investigation; a journal of technical methods and pathology 76 (4 …, 1997
521997
Quality standards for predialysis education: results from a consensus conference
C Isnard Bagnis, C Crepaldi, J Dean, T Goovaerts, S Melander, ...
Nephrology Dialysis Transplantation 30 (7), 1058-1066, 2015
482015
The system can't perform the operation now. Try again later.
Articles 1–20